Celebrating 25 Years of Excellence

This year marks an extraordinary milestone as Bioscience Valuation (BSV) celebrates its 25th anniversary! From our beginnings in the early 2000s, when our co-founders Dr. Kerstin Bode-Greuel and Joachim Greuel were pioneers in applying rigorous financial models to the life sciences, to becoming a trusted partner for biotech, medtech, pharma companies, investment funds, research institutes, and universities, it has been such a rewarding journey. Their publications continue to influence business schools and guide the industry to this day.

“Over the past 25 years, we've weathered challenges such as the 2008 financial crisis, facilitated spectacular licensing deals as well as successful funding rounds and assisted extraordinary exits. We supported scientific and commercial due diligence processes to inform investment decisions as well as the development and commercialization of life-changing treatments” said Kerstin Bode-Greuel. Joachim Greuel added “Our progress and achievements are thanks to the dedication of our exceptional teams, clients, and partners. A big heart-felt ‘thank you’ to everyone who has joined and supported us throughout all those years”.

Cheers to a phenomenal first quarter of a century of BSV existence, and cheers to the next!